fluorouracil has been researched along with idelalisib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AF; Chiang, PL; Dai, CF; Huang, CY; Hwang, TL; Liaw, CC; Sheu, JH; Su, JH; Sung, PJ | 1 |
| Yang, S; Yao, Z; Zhang, N; Zhang, X; Zhu, Z | 1 |
2 other study(ies) available for fluorouracil and idelalisib
| Article | Year |
|---|---|
Bioactive new withanolides from the cultured soft coral Sinularia brassica.
Topics: Animals; Anthozoa; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Cytochalasin B; Humans; Models, Molecular; Neoplasms; Neutrophils; Pancreatic Elastase; Superoxides; Withanolides | 2017 |
Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Synergism; eIF-2 Kinase; Fluorouracil; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HT29 Cells; Humans; Mice; Phenylurea Compounds; Proto-Oncogene Proteins; Purines; Pyridines; Quinazolinones; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |